These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 30810932)
1. In silico identification of potential inhibitors against shikimate dehydrogenase through virtual screening and toxicity studies for the treatment of tuberculosis. Isa MA; Majumdar RS; Haider S Int Microbiol; 2019 Mar; 22(1):7-17. PubMed ID: 30810932 [TBL] [Abstract][Full Text] [Related]
2. In silico docking and molecular dynamics simulation of 3-dehydroquinate synthase (DHQS) from Mycobacterium tuberculosis. Isa MA; Majumdhar RS; Haider S J Mol Model; 2018 May; 24(6):132. PubMed ID: 29752576 [TBL] [Abstract][Full Text] [Related]
3. Comparative modeling and dynamic simulation of UDP-N-acetylmuramoyl-alanine ligase (MurC) from Mycobacterium tuberculosis through virtual screening and toxicity analysis. Isa MA Life Sci; 2020 Dec; 262():118466. PubMed ID: 32961233 [TBL] [Abstract][Full Text] [Related]
4. Integration of virtual screening and susceptibility test to discover active-site subpocket-specific biogenic inhibitors of Helicobacter pylori shikimate dehydrogenase. Wang K; Zhu M; Tang Y; Liu J; Yan F; Yu Z; Zhu J Int Microbiol; 2019 Mar; 22(1):69-80. PubMed ID: 30810934 [TBL] [Abstract][Full Text] [Related]
5. Homology modeling and molecular dynamic simulation of UDP-N-acetylmuramoyl-l-alanine-d-glutamate ligase (MurD) from Mycobacterium tuberculosis H37Rv using in silico approach. Isa MA Comput Biol Chem; 2019 Feb; 78():116-126. PubMed ID: 30504089 [TBL] [Abstract][Full Text] [Related]
9. Virtual Screening of Small Molecular Inhibitors against DprE1. Zhang G; Guo S; Cui H; Qi J Molecules; 2018 Feb; 23(3):. PubMed ID: 29495447 [TBL] [Abstract][Full Text] [Related]
10. Structure-based virtual screening as a tool for the identification of novel inhibitors against Mycobacterium tuberculosis 3-dehydroquinate dehydratase. Petersen GO; Saxena S; Renuka J; Soni V; Yogeeswari P; Santos DS; Bizarro CV; Sriram D J Mol Graph Model; 2015 Jul; 60():124-31. PubMed ID: 26043661 [TBL] [Abstract][Full Text] [Related]
11. Identification of potent inhibitors of ATP synthase subunit c (AtpE) from Isa MA; Abubakar MB; Mohammed MM; Ibrahim MM; Gubio FA Heliyon; 2021 Dec; 7(12):e08482. PubMed ID: 34934830 [TBL] [Abstract][Full Text] [Related]
12. Drug targeted virtual screening and molecular dynamics of LipU protein of Mycobacterium tuberculosis and Mycobacterium leprae. Kaur G; Pandey B; Kumar A; Garewal N; Grover A; Kaur J J Biomol Struct Dyn; 2019 Mar; 37(5):1254-1269. PubMed ID: 29557724 [TBL] [Abstract][Full Text] [Related]
13. Development of potent chemical antituberculosis agents targeting Mycobacterium tuberculosis acetohydroxyacid synthase. Jung IP; Ha NR; Lee SC; Ryoo SW; Yoon MY Int J Antimicrob Agents; 2016 Sep; 48(3):247-58. PubMed ID: 27451857 [TBL] [Abstract][Full Text] [Related]
14. Screening of Anti-mycobacterial Phytochemical Compounds for Potential Inhibitors against Mycobacterium Tuberculosis Isocitrate Lyase. Tiwari A; Kumar A; Srivastava G; Sharma A Curr Top Med Chem; 2019; 19(8):600-608. PubMed ID: 30836915 [TBL] [Abstract][Full Text] [Related]
15. Pharmacoinformatics exploration of polyphenol oxidases leading to novel inhibitors by virtual screening and molecular dynamic simulation study. Hassan M; Abbas Q; Ashraf Z; Moustafa AA; Seo SY Comput Biol Chem; 2017 Jun; 68():131-142. PubMed ID: 28340400 [TBL] [Abstract][Full Text] [Related]